Skip to main content
. 2022 Jul 2;157:155957. doi: 10.1016/j.cyto.2022.155957

Table 2.

IFITM3 rs12252 association with COVID-19 mortality.

Groups
Model Genotype Improved patients Dead patients OR (95% CI) P-value AIC BIC
Allele T 1041 (83.0%) 568 (52.0%)
C 219 (17.0%) 528 (48.0%)
Codominant T/T 458 (72.7%) 212 (38.7%) 1.00 <0.0001
1450.9
1466.1
C/T 125 (19.8%) 144 (26.3%) 2.49 (1.86–3.33)
C/C 47 (7.5%) 192 (35.0%) 8.83 (6.17–12.63)
Dominant T/T 458 (72.7%) 212 (38.7%) 1.00 <0.0001
1490.7
1500.8
C/T-C/C 172 (27.3%) 336 (61.3%) 4.22 (3.30–5.39)
Recessive T/T-C/T 583 (92.5%) 356 (65.0%) 1.00 <0.0001
1487.3
1497.4
C/C 47 (7.5%) 192 (35.0%) 6.69 (4.74–9.45)
Overdominant T/T-C/C 505 (80.2%) 404 (73.7%) 1.00 0.0087 1624.5 1634.6
C/T 125 (19.8%) 144 (26.3%) 1.44 (1.10–1.89)
Minor allele frequency (C) 0.17 0.48

OR: Odds ratios; CI: confidence intervals; AIC: Akaike information criterion; BIC: Bayesian information criterion.